Stryker Corporation operates through three segments. The Orthopaedics segment offers implants used in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment provides surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling and emergency medical equipment, and reprocessed and remanufactured medical devices, as well as other medical device products for use in various medical specialties. The Neurotechnology and Spine segment offers neurosurgical and neurovascular devices that include products used for minimally invasive endovascular techniques. The company was founded in 1941 and is based in Kalamazoo, Michigan.
Understanding The Dividend Growth Income+ Club Approach Total Return, Dividends, Share Price Undertaking exercises to determine the current value of a stock is a waste of time, when the market continually provides the only current value that matters when it comes to buy a stock. The only way an investor...
Robert Honeywill on Seeking Alpha | September 21, 2020
SALEM, Ore. , Sept. 16, 2020 /PRNewswire/ -- Willamette Surgery Center is the first ambulatory surgery center in Salem, Oregon to offer robotic-arm assisted total knee, partial knee and total hip replacements with Stryker's Mako System. This highly advanced robotic technology transforms the way joint replacement surgery is performed, enabling surgeons to have a more predictable surgical experience with increased accuracy. 1,2,3,4 Willamette Surgery Center's first surgical procedure with Mako is scheduled for September 21, 2020 . Shane Hess , DO, an orthopedic surgeon at Hope Orthopedics of Oregon , will be performing the total knee replacement and says, "Robotic-arm assisted surgery with Mako technology adds a … Full story available on Benzinga.com
DUBLIN--(BUSINESS WIRE)--The "Spinal Fusion: Implanted Instrumentation" report has been added to ResearchAndMarkets.com's offering. Sales of implanted instrumentation for spinal fusion procedures totaled approximately $4.4bn in 2019, with sales expected to climb at a CAGR of 2.2% through 2024. Growth in the spinal fusion instrumentation market is being driven by several factors including the prevalence of degenerative disc disease, new surgical techniques and associated instrumentation that hav